DFX Intelligence
Northlane Capital Partners and United States Drug Testing Laboratories, Inc.
Platform acquisition deal· Des Plaines, IL
Business services, IL.
No date on record · this record
- Announced
- Jan 28, 2025
- Firms on the deal team
- 1
- Capital providers
- 2
No date on record · this record
The buyer on this deal is not served as an independent sponsor (a strategic acquirer, or a lender recorded as the buyer). The deal team is shown, and it is not counted in any firm's independent sponsor deals.
Independent sponsor
No principal is named in the announcement.
Equity partners
- Stellus Capital Management · Equity providerColin Baker
- Stellus Capital Management · LenderColin Baker
Debt
- Stellus Capital Management · Equity providerColin Baker
- Stellus Capital Management · LenderColin Baker
The announcement
Stellus provided senior debt financing and an equity co-investment in support of Northlane Capital Partners' investment in founder-owned USDTL of Des Plaines, Illinois.
DFX analyst research (General-assisted, every claim URL-cited) stelluscapital.com
Deal teamHow a firm is placed on a dealA firm is on this deal when the announcement, a filing, or the firm's own deal page names it in the role. Medium confidence (a biography naming the deal, or a side read from the sentence) is labelled; anything weaker is not shown.
Sell-side advisor
- Brown, Gibbons, Lang & Company · Sell-side advisor for United States Drug Testing Laboratories, Inc.Brown Gibbons Lang & Company2025-01-13